US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 15.620
  • +0.410+2.70%
Close Nov 29 13:00 ET
  • 15.600
  • -0.020-0.13%
Post 16:40 ET
1.59BMarket Cap-2866P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-23.01%658.11M
-23.90%691.07M
-15.24%791.29M
-23.51%912.22M
-23.51%912.22M
3.21%854.79M
3.87%908.07M
9.15%933.54M
59.29%1.19B
59.29%1.19B
-Cash and cash equivalents
-28.29%120.5M
-23.84%130.85M
-41.53%171.98M
-56.69%226.75M
-56.69%226.75M
19.00%168.03M
16.26%171.81M
120.53%294.15M
324.21%523.51M
324.21%523.51M
-Short-term investments
-21.72%537.62M
-23.91%560.22M
-3.14%619.32M
2.44%685.48M
2.44%685.48M
-0.03%686.76M
1.35%736.27M
-11.43%639.39M
7.01%669.12M
7.01%669.12M
Receivables
36.40%8.85M
143.85%12.33M
642.50%36.43M
867.52%36.46M
867.52%36.46M
61.35%6.49M
77.15%5.06M
172.40%4.91M
85.52%3.77M
85.52%3.77M
-Accounts receivable
36.40%8.85M
143.85%12.33M
642.50%36.43M
867.52%36.46M
867.52%36.46M
61.35%6.49M
77.15%5.06M
172.40%4.91M
85.52%3.77M
85.52%3.77M
Other current assets
36.38%43.93M
103.19%53.81M
123.30%56.32M
143.30%49.65M
143.30%49.65M
20.52%32.21M
44.70%26.49M
37.72%25.22M
9.81%20.41M
9.81%20.41M
Total current assets
-20.44%710.9M
-19.41%757.21M
-8.26%884.04M
-17.95%998.33M
-17.95%998.33M
4.02%893.49M
4.93%939.62M
10.09%963.67M
58.17%1.22B
58.17%1.22B
Non current assets
Net PPE
-15.39%129.09M
-13.44%135.69M
-10.87%142.5M
-7.99%148.14M
-7.99%148.14M
19.30%152.58M
57.31%156.74M
59.60%159.87M
60.82%161M
60.82%161M
-Gross PPE
-15.39%129.09M
-13.44%135.69M
-10.87%142.5M
-3.19%188M
-3.19%188M
19.30%152.58M
57.31%156.74M
59.60%159.87M
53.85%194.2M
53.85%194.2M
-Accumulated depreciation
----
----
----
-20.07%-39.86M
-20.07%-39.86M
----
----
----
-27.13%-33.2M
-27.13%-33.2M
Investments and advances
60.44%316.52M
24.22%281.82M
-20.83%233.05M
8.57%154.51M
8.57%154.51M
102.08%197.28M
96.69%226.88M
29.53%294.35M
-66.52%142.32M
-66.52%142.32M
Other non current assets
--16.84M
--16.82M
----
----
----
----
----
----
----
----
Total non current assets
32.18%462.45M
13.22%434.33M
-17.32%375.55M
-0.22%302.65M
-0.22%302.65M
55.14%349.86M
78.44%383.63M
38.73%454.22M
-42.24%303.32M
-42.24%303.32M
Total assets
-5.63%1.17B
-9.95%1.19B
-11.16%1.26B
-14.42%1.3B
-14.42%1.3B
14.65%1.24B
19.17%1.32B
17.88%1.42B
17.43%1.52B
17.43%1.52B
Liabilities
Current liabilities
Payables
269.97%13.15M
61.73%18.82M
98.68%13.69M
44.59%7.45M
44.59%7.45M
-18.96%3.55M
54.81%11.63M
-32.04%6.89M
-46.61%5.15M
-46.61%5.15M
-accounts payable
269.97%13.15M
61.73%18.82M
98.68%13.69M
44.59%7.45M
44.59%7.45M
-18.96%3.55M
54.81%11.63M
-32.04%6.89M
-46.61%5.15M
-46.61%5.15M
Current accrued expenses
-17.09%30.66M
-10.63%30.23M
-5.38%32.89M
3.34%40.4M
3.34%40.4M
-8.61%36.97M
5.72%33.82M
9.57%34.76M
70.36%39.1M
70.36%39.1M
Current debt and capital lease obligation
12.32%19.18M
13.21%18.96M
14.91%18.76M
11.47%18.6M
11.47%18.6M
26.00%17.07M
75.06%16.75M
74.86%16.33M
83.11%16.69M
83.11%16.69M
-Current capital lease obligation
12.32%19.18M
13.21%18.96M
14.91%18.76M
11.47%18.6M
11.47%18.6M
26.00%17.07M
75.06%16.75M
74.86%16.33M
83.11%16.69M
83.11%16.69M
Current deferred liabilities
65.99%22.16M
1.14%22.18M
-37.23%22.18M
-49.50%22.14M
-49.50%22.14M
-75.65%13.35M
-64.51%21.93M
-44.57%35.34M
-31.24%43.84M
-31.24%43.84M
Current liabilities
14.93%105.68M
5.25%105.09M
-5.29%97.91M
-8.97%115.21M
-8.97%115.21M
-29.88%91.95M
-19.32%99.85M
-18.02%103.38M
0.57%126.55M
0.57%126.55M
Non current liabilities
Long term debt and capital lease obligation
-18.58%82.45M
-17.29%87.33M
-16.12%92.1M
-15.15%96.75M
-15.15%96.75M
20.41%101.26M
75.98%105.58M
75.74%109.8M
75.65%114.02M
75.65%114.02M
-Long term capital lease obligation
-18.58%82.45M
-17.29%87.33M
-16.12%92.1M
-15.15%96.75M
-15.15%96.75M
20.41%101.26M
75.98%105.58M
75.74%109.8M
75.65%114.02M
75.65%114.02M
Non current deferred liabilities
77.74%22.61M
117.14%28.05M
141.24%33.44M
94.93%38.85M
94.93%38.85M
-50.47%12.72M
-63.43%12.92M
-71.99%13.86M
-68.60%19.93M
-68.60%19.93M
Other non current liabilities
----
----
----
----
----
----
----
----
--24.03M
--24.03M
Total non current liabilities
-7.83%105.05M
-2.63%115.38M
1.52%125.54M
-14.16%135.6M
-14.16%135.6M
-11.21%113.98M
11.67%118.5M
0.60%123.66M
23.05%157.98M
23.05%157.98M
Total liabilities
2.33%210.74M
0.97%220.47M
-1.58%223.45M
-11.85%250.81M
-11.85%250.81M
-20.64%205.94M
-5.01%218.35M
-8.83%227.05M
11.92%284.53M
11.92%284.53M
Shareholders'equity
Share capital
11.11%10K
11.11%10K
11.11%10K
0.00%9K
0.00%9K
12.50%9K
12.50%9K
12.50%9K
28.57%9K
28.57%9K
-common stock
11.11%10K
11.11%10K
11.11%10K
0.00%9K
0.00%9K
12.50%9K
12.50%9K
12.50%9K
28.57%9K
28.57%9K
Retained earnings
-34.22%-2.05B
-36.24%-1.91B
-37.92%-1.77B
-40.88%-1.66B
-40.88%-1.66B
-43.47%-1.53B
-47.70%-1.4B
-50.65%-1.28B
-67.45%-1.18B
-67.45%-1.18B
Paid-in capital
17.16%3.01B
14.81%2.88B
13.30%2.8B
12.01%2.71B
12.01%2.71B
35.25%2.57B
36.51%2.51B
36.55%2.47B
38.63%2.42B
38.63%2.42B
Gains losses not affecting retained earnings
192.30%3.3M
70.14%-1.16M
64.64%-947K
69.74%-2.26M
69.74%-2.26M
61.87%-3.57M
59.51%-3.87M
66.78%-2.68M
-183.47%-7.46M
-183.47%-7.46M
Total stockholders'equity
-7.21%962.62M
-12.11%971.06M
-12.99%1.04B
-15.01%1.05B
-15.01%1.05B
25.75%1.04B
25.48%1.1B
24.86%1.19B
18.78%1.24B
18.78%1.24B
Total equity
-7.21%962.62M
-12.11%971.06M
-12.99%1.04B
-15.01%1.05B
-15.01%1.05B
25.75%1.04B
25.48%1.1B
24.86%1.19B
18.78%1.24B
18.78%1.24B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -23.01%658.11M-23.90%691.07M-15.24%791.29M-23.51%912.22M-23.51%912.22M3.21%854.79M3.87%908.07M9.15%933.54M59.29%1.19B59.29%1.19B
-Cash and cash equivalents -28.29%120.5M-23.84%130.85M-41.53%171.98M-56.69%226.75M-56.69%226.75M19.00%168.03M16.26%171.81M120.53%294.15M324.21%523.51M324.21%523.51M
-Short-term investments -21.72%537.62M-23.91%560.22M-3.14%619.32M2.44%685.48M2.44%685.48M-0.03%686.76M1.35%736.27M-11.43%639.39M7.01%669.12M7.01%669.12M
Receivables 36.40%8.85M143.85%12.33M642.50%36.43M867.52%36.46M867.52%36.46M61.35%6.49M77.15%5.06M172.40%4.91M85.52%3.77M85.52%3.77M
-Accounts receivable 36.40%8.85M143.85%12.33M642.50%36.43M867.52%36.46M867.52%36.46M61.35%6.49M77.15%5.06M172.40%4.91M85.52%3.77M85.52%3.77M
Other current assets 36.38%43.93M103.19%53.81M123.30%56.32M143.30%49.65M143.30%49.65M20.52%32.21M44.70%26.49M37.72%25.22M9.81%20.41M9.81%20.41M
Total current assets -20.44%710.9M-19.41%757.21M-8.26%884.04M-17.95%998.33M-17.95%998.33M4.02%893.49M4.93%939.62M10.09%963.67M58.17%1.22B58.17%1.22B
Non current assets
Net PPE -15.39%129.09M-13.44%135.69M-10.87%142.5M-7.99%148.14M-7.99%148.14M19.30%152.58M57.31%156.74M59.60%159.87M60.82%161M60.82%161M
-Gross PPE -15.39%129.09M-13.44%135.69M-10.87%142.5M-3.19%188M-3.19%188M19.30%152.58M57.31%156.74M59.60%159.87M53.85%194.2M53.85%194.2M
-Accumulated depreciation -------------20.07%-39.86M-20.07%-39.86M-------------27.13%-33.2M-27.13%-33.2M
Investments and advances 60.44%316.52M24.22%281.82M-20.83%233.05M8.57%154.51M8.57%154.51M102.08%197.28M96.69%226.88M29.53%294.35M-66.52%142.32M-66.52%142.32M
Other non current assets --16.84M--16.82M--------------------------------
Total non current assets 32.18%462.45M13.22%434.33M-17.32%375.55M-0.22%302.65M-0.22%302.65M55.14%349.86M78.44%383.63M38.73%454.22M-42.24%303.32M-42.24%303.32M
Total assets -5.63%1.17B-9.95%1.19B-11.16%1.26B-14.42%1.3B-14.42%1.3B14.65%1.24B19.17%1.32B17.88%1.42B17.43%1.52B17.43%1.52B
Liabilities
Current liabilities
Payables 269.97%13.15M61.73%18.82M98.68%13.69M44.59%7.45M44.59%7.45M-18.96%3.55M54.81%11.63M-32.04%6.89M-46.61%5.15M-46.61%5.15M
-accounts payable 269.97%13.15M61.73%18.82M98.68%13.69M44.59%7.45M44.59%7.45M-18.96%3.55M54.81%11.63M-32.04%6.89M-46.61%5.15M-46.61%5.15M
Current accrued expenses -17.09%30.66M-10.63%30.23M-5.38%32.89M3.34%40.4M3.34%40.4M-8.61%36.97M5.72%33.82M9.57%34.76M70.36%39.1M70.36%39.1M
Current debt and capital lease obligation 12.32%19.18M13.21%18.96M14.91%18.76M11.47%18.6M11.47%18.6M26.00%17.07M75.06%16.75M74.86%16.33M83.11%16.69M83.11%16.69M
-Current capital lease obligation 12.32%19.18M13.21%18.96M14.91%18.76M11.47%18.6M11.47%18.6M26.00%17.07M75.06%16.75M74.86%16.33M83.11%16.69M83.11%16.69M
Current deferred liabilities 65.99%22.16M1.14%22.18M-37.23%22.18M-49.50%22.14M-49.50%22.14M-75.65%13.35M-64.51%21.93M-44.57%35.34M-31.24%43.84M-31.24%43.84M
Current liabilities 14.93%105.68M5.25%105.09M-5.29%97.91M-8.97%115.21M-8.97%115.21M-29.88%91.95M-19.32%99.85M-18.02%103.38M0.57%126.55M0.57%126.55M
Non current liabilities
Long term debt and capital lease obligation -18.58%82.45M-17.29%87.33M-16.12%92.1M-15.15%96.75M-15.15%96.75M20.41%101.26M75.98%105.58M75.74%109.8M75.65%114.02M75.65%114.02M
-Long term capital lease obligation -18.58%82.45M-17.29%87.33M-16.12%92.1M-15.15%96.75M-15.15%96.75M20.41%101.26M75.98%105.58M75.74%109.8M75.65%114.02M75.65%114.02M
Non current deferred liabilities 77.74%22.61M117.14%28.05M141.24%33.44M94.93%38.85M94.93%38.85M-50.47%12.72M-63.43%12.92M-71.99%13.86M-68.60%19.93M-68.60%19.93M
Other non current liabilities ----------------------------------24.03M--24.03M
Total non current liabilities -7.83%105.05M-2.63%115.38M1.52%125.54M-14.16%135.6M-14.16%135.6M-11.21%113.98M11.67%118.5M0.60%123.66M23.05%157.98M23.05%157.98M
Total liabilities 2.33%210.74M0.97%220.47M-1.58%223.45M-11.85%250.81M-11.85%250.81M-20.64%205.94M-5.01%218.35M-8.83%227.05M11.92%284.53M11.92%284.53M
Shareholders'equity
Share capital 11.11%10K11.11%10K11.11%10K0.00%9K0.00%9K12.50%9K12.50%9K12.50%9K28.57%9K28.57%9K
-common stock 11.11%10K11.11%10K11.11%10K0.00%9K0.00%9K12.50%9K12.50%9K12.50%9K28.57%9K28.57%9K
Retained earnings -34.22%-2.05B-36.24%-1.91B-37.92%-1.77B-40.88%-1.66B-40.88%-1.66B-43.47%-1.53B-47.70%-1.4B-50.65%-1.28B-67.45%-1.18B-67.45%-1.18B
Paid-in capital 17.16%3.01B14.81%2.88B13.30%2.8B12.01%2.71B12.01%2.71B35.25%2.57B36.51%2.51B36.55%2.47B38.63%2.42B38.63%2.42B
Gains losses not affecting retained earnings 192.30%3.3M70.14%-1.16M64.64%-947K69.74%-2.26M69.74%-2.26M61.87%-3.57M59.51%-3.87M66.78%-2.68M-183.47%-7.46M-183.47%-7.46M
Total stockholders'equity -7.21%962.62M-12.11%971.06M-12.99%1.04B-15.01%1.05B-15.01%1.05B25.75%1.04B25.48%1.1B24.86%1.19B18.78%1.24B18.78%1.24B
Total equity -7.21%962.62M-12.11%971.06M-12.99%1.04B-15.01%1.05B-15.01%1.05B25.75%1.04B25.48%1.1B24.86%1.19B18.78%1.24B18.78%1.24B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme ARK Portfolio
ARK Portfolio
Intraday+2.57%
Gene Editing
Gene Editing
Intraday+0.54%